Inhibition of Transfer Messenger RNA Aminoacylation and trans -Translation by Aminoglycoside Antibiotics

Abstract : Transfer messenger RNA (tmRNA) directs the modification of proteins of which the biosynthesis has stalled or has been interrupted. Here, we report that aminoglycosides can interfere with this quality control system in bacteria, termed trans-translation. Neomycin B is the strongest inhibitor of tmRNA aminoacylation with alanine (K(i) value of approximately 35 micro m), an essential step during trans-translation. The binding sites of neomycin B do not overlap with the identity determinants for alanylation, but the aminoglycoside perturbs the conformation of the acceptor stem that contains the aminoacylation signals. Aminoglycosides reduce the conformational freedom of the transfer RNA-like domain of tmRNA. Additional contacts between aminoglycosides and tmRNA are within the tag reading frame, probably also disturbing reprogramming of the stalled ribosomes prior protein tagging. Aminoglycosides impair tmRNA aminoacylation in the presence of all of the transfer RNAs from Escherichia coli, small protein B, and elongation factor Tu, but when both proteins are present, the inhibition constant is 1 order of magnitude higher. SmpB and elongation factor Tu have RNA chaperone activities, ensuring that tmRNA adopts an optimal conformation during aminoacylation.
Liste complète des métadonnées

https://hal-normandie-univ.archives-ouvertes.fr/hal-02262535
Contributeur : Sophie Corvaisier <>
Soumis le : vendredi 2 août 2019 - 16:47:28
Dernière modification le : dimanche 4 août 2019 - 01:09:08

Lien texte intégral

Identifiants

Citation

Sophie Corvaisier, Valérie Bordeau, Brice Felden. Inhibition of Transfer Messenger RNA Aminoacylation and trans -Translation by Aminoglycoside Antibiotics. Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2003, 278 (17), pp.14788-14797. ⟨10.1074/jbc.M212830200⟩. ⟨hal-02262535⟩

Partager

Métriques

Consultations de la notice

16